Biosimilar Newsletter Archive
-
08.30.22 -- You're One Partner Away From Bringing Your Biotherapy To Life
8/30/2022
08/30/22 Biosimilar Development Newsletter
-
08.25.22 -- What's The Environmental Impact Of Biopharma Continuous Manufacturing?
8/25/2022
08/25/22 Biosimilar Development Newsletter
-
08.18.22 -- The Near Future Of Regulatory Info Management In EU
8/18/2022
08/18/22 Biosimilar Development Newsletter
-
08.16.22 -- Assessing Risk And Reducing Complexity For Drug Delivery
8/16/2022
08/16/22 Biosimilar Development Newsletter
-
08.11.22 -- Inside Gamma Delta T Cells, Innate Immunity & Mouse Models, and more podcast episodes!
8/11/2022
08/11/22 Biosimilar Development Newsletter
-
08.11.22 -- FDA Approves First Interchangeable Lucentis Biosimilar
8/11/2022
08/11/22 Biosimilar Development Newsletter
-
08.10.22 -- The Value Of SPR
8/10/2022
08/10/22 Biosimilar Development Newsletter
-
08.04.22 -- Strategic Outsourcing Demand: Selecting A CDMO
8/4/2022
08/04/22 Biosimilar Development Newsletter
-
08.04.22 -- FDA, EMA Accept MS Biosimilar Applications
8/4/2022
08/04/22 Biosimilar Development Newsletter
-
07.28.22 -- The Need For Creative Funding For Life Sciences
7/28/2022
07/28/22 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more